Correlation of quantitative p95HER2 and HER2 protein expression with pathologic complete response (pCR) in HER2-positive breast cancer patients (pts) treated with neoadjuvant (NEO) trastuzumab-containing therapy.
Jose Caetano Villasboas
No relevant relationships to disclose
Judith Hurley
No relevant relationships to disclose
Jodi Marie Weidler
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Agnes Paquet
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Carmen Gomez Fernandez
No relevant relationships to disclose
Maureen Cioffi Lavina
No relevant relationships to disclose
Jeff Sperinde
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Ahmed Chenna
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Mojgan Haddad
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Yolanda Lie
Employment or Leadership Position - Monogram Biosciences
John William Winslow
Employment or Leadership Position - Monogram Biosciences
Weidong Huang
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Christos J. Petropoulos
Employment or Leadership Position - Monogram Biosciences
Stock Ownership - LabCorp
Mark D. Pegram
No relevant relationships to disclose